How should sertraline (Zoloft) 25 mg be tapered for discontinuation?

Tapering Zoloft 25mg for Discontinuation

Sertraline (Zoloft) 25mg should be tapered gradually over 2-4 weeks by reducing to 12.5mg for 1-2 weeks, then stopping, to minimize discontinuation syndrome symptoms. 1

Understanding Discontinuation Risk

Sertraline is specifically associated with discontinuation syndrome, though to a lesser extent than paroxetine or fluvoxamine 2. The syndrome manifests as dizziness, fatigue, lethargy, general malaise, myalgias, chills, headaches, nausea, vomiting, diarrhea, insomnia, imbalance, vertigo, sensory disturbances, paresthesias, anxiety, irritability, and agitation 2.

Standard Tapering Approach for 25mg

Since you're already at a low dose (25mg), the taper is straightforward:

• Week 1-2: Reduce to 12.5mg daily (half tablet)
• Week 3-4: Stop completely

This follows the FDA-approved labeling guidance that dose tapering is advisable when discontinuing to reduce discontinuation syndrome risk 1.

Alternative Approaches Based on Risk Factors

For patients at LOW risk (short duration of use <6 months, no prior withdrawal difficulties):

• The 2-4 week taper above is appropriate 3
• Some may tolerate stopping 25mg directly after 1 week at 12.5mg

For patients at HIGHER risk (longer duration >12 months, prior withdrawal symptoms, anxiety sensitivity):

• Extend the taper: 12.5mg for 2-4 weeks, then consider 6.25mg (quarter tablet) for another 1-2 weeks before stopping 3, 4
• Recent evidence suggests hyperbolic tapering (smaller reductions as dose decreases) may minimize withdrawal symptoms better than linear tapers 4

Monitoring During Discontinuation

Contact the patient within 1 week of starting the taper to assess for withdrawal symptoms 5. This can be done by phone or in-person. Watch specifically for:

• New onset dizziness, "brain zaps," or sensory disturbances
• Flu-like symptoms (myalgias, chills, fatigue)
• Mood changes (anxiety, irritability, agitation)
• GI symptoms (nausea, diarrhea)

Critical distinction: Withdrawal symptoms typically emerge within 2-7 days of dose reduction and are self-limited (resolving within 1-2 weeks), whereas depression relapse typically occurs weeks later and persists 6.

If Withdrawal Symptoms Occur

• Mild symptoms: Reassure patient they are transient and self-limiting 6
• Moderate-to-severe symptoms: Reinstitute the previous dose and slow the taper rate (e.g., extend each step to 2-4 weeks instead of 1-2 weeks) 6
• Do not mistake withdrawal for relapse and unnecessarily restart full-dose treatment

Common Pitfalls to Avoid

1. Abrupt discontinuation: Never stop 25mg suddenly without tapering—this significantly increases withdrawal risk 2, 7
2. Confusing withdrawal with relapse: Withdrawal is immediate (days) and includes physical symptoms; relapse is delayed (weeks) and primarily mood symptoms 7
3. Inadequate follow-up: Patients need contact within the first week to catch withdrawal symptoms early 5
4. Ignoring duration of use: Patients on sertraline >12 months need slower tapers 3, 8

Special Considerations

• Liquid formulation: If tablets cannot be split small enough for very gradual tapers in high-risk patients, sertraline oral solution (20mg/mL) allows precise dosing down to 1mg increments 1, 3
• Concomitant medications: Ensure patient is not taking disulfiram if using oral solution (contains 12% alcohol) 1